Nevada 2025 Regular Session

Nevada Senate Bill SB157

Refer
2/2/25  
Introduced
2/3/25  
Report Pass
3/24/25  
Engrossed
3/31/25  
Refer
3/31/25  
Report Pass
5/23/25  
Enrolled
6/1/25  
Chaptered
6/6/25  

Caption

Revises provisions relating to the testing of cannabis and cannabis products. (BDR 56-962)

Summary

SB157 revises Nevada’s cannabis regulatory framework by requiring the Cannabis Compliance Board to adopt rules specifically governing the testing of cannabis and cannabis products. The bill moves testing from a discretionary area of regulation to a mandatory one, and it directs the Board to establish detailed standards for representative sampling, laboratory testing, and the handling of cannabis lots. It also defines key terms such as “lot” and “harvest batch” to create more uniform testing requirements across the industry. The bill requires representative samples from each lot to be tested by an independent cannabis testing laboratory and ties sampling procedures to the ASTM International standard for post-harvest cannabis/hemp sampling. It also sets minimum sample weights for cannabis flower lots of different sizes, which is intended to standardize how testing samples are collected and reduce ambiguity in compliance practices. In addition, the bill leaves in place broader Board authority over cannabis regulation and does not alter the basic licensing structure, but it adds more specific operational requirements for cultivators, processors, and testing labs. Beyond testing, the bill reinforces existing Board duties in related areas, including regulation of unlicensed cannabis activity and the collection of demographic data on cannabis business owners, managers, and agent card holders. Those provisions continue Nevada’s broader policy approach of monitoring the industry, supporting enforcement, and tracking diversity and participation in the market. The bill also references the Board’s authority to create a pilot program for emerging small cannabis businesses, though the core change in SB157 is the mandatory testing rulemaking. The general sentiment reflected in the voting history is strongly favorable, with unanimous Senate passage and substantial Assembly support. That suggests broad legislative agreement that cannabis testing standards should be clarified and made more consistent. No committee transcript was provided, so there is no recorded debate in the materials about opposition or amendments, but the final vote pattern indicates the bill was largely noncontroversial. The main points of contention, to the extent they can be inferred from the text, would likely concern the compliance burden on cannabis businesses and testing laboratories, especially the new sampling thresholds and the requirement to align with ASTM standards. Industry participants may also focus on how the Board defines lots and enforces sampling procedures, since those details can affect costs, product throughput, and laboratory workload. However, the available record does not show organized opposition, and the final votes suggest any concerns did not prevent passage.

Impact

SB157 amends Nevada cannabis law by converting the Cannabis Compliance Board’s authority to regulate testing into a duty to do so and by adding new statutory requirements for sampling and laboratory testing. It directly affects NRS 678A.450 and adds new provisions to Chapter 678B governing cannabis testing, lot definitions, and sample collection standards. The bill primarily impacts cannabis cultivation facilities, independent testing laboratories, and other licensees or registrants subject to testing compliance, while also reinforcing related regulatory and reporting obligations for the Board.

Sentiment

The bill appears to have been received positively overall. It passed the Senate unanimously and the Assembly with a clear majority, indicating broad bipartisan support for more specific cannabis testing standards. The absence of committee transcript material limits insight into detailed debate, but the voting record suggests the measure was viewed as a technical regulatory update rather than a controversial policy shift.

Contention

Any likely contention centers on implementation details rather than the bill’s overall purpose. Cannabis businesses and testing laboratories may be concerned about the cost and administrative burden of mandatory representative sampling, the minimum sample weights, and the requirement that Board standards align with ASTM sampling guidance. There may also be practical questions about how the Board defines and enforces “lot” and “harvest batch” classifications. No explicit opposition is shown in the provided record, and the strong vote totals suggest these issues did not generate significant legislative resistance.

Companion Bills

No companion bills found.

Previously Filed As

NV AB8

Cannabis: cannabinoids: industrial hemp.

NV AB203

Revises provisions relating to cannabis. (BDR 56-134)

NV SB168

Revises provisions relating to cannabis. (BDR 56-553)

NV LD1847

An Act to Institute Testing and Tracking of Medical Use Cannabis and Cannabis Products Similar to Adult Use Cannabis and Cannabis Products, Dedicate a Portion of the Adult Use Cannabis Sales and Excise Tax to Medical Use Cannabis Programs and Create a Study Group

NV AB76

Revises provisions relating to cannabis. (BDR 56-286)

NV AB2250

Cannabis: cannabinoids.

NV AB149

Revises provisions relating to cannabis. (BDR 56-51)

NV SB00970

An Act Concerning Cannabinoids, Hemp And Hemp Products.

NV AB307

Revises provisions governing the taxation of sales of cannabis and cannabis products. (BDR 32-149)

NV SF2165

Medical cannabis combination business plant canopy increase to cultivate cannabis sold as medical cannabis flower or medical cannabinoid products provision

Similar Bills

No similar bills found.